Results 121 to 130 of about 1,107,761 (194)

Age-related increase in plasma p-tau217 in amyloid-beta-negative cognitively unimpaired individuals affects diagnostic interpretation. [PDF]

Alzheimers Dement
Mammel AE, Gonzalez-Ortiz F, Mousavi A, Hallett K, Encarnacion M, Biehl D, Gill P, Ismael S, Fowler C, Doecke JD, Ward L, Frykman H.   +11 more
europepmc   +1 more source

Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer's Disease. [PDF]

Pathophysiology
Gasca-Martínez Y, Ontiveros-Torres MA, López-Gallegos I, Jarero-Basulto JJ.   +3 more
europepmc   +1 more source

Amyloid beta exacerbates Tau-seeded pathology and drives tangle formation in human neuronal xenografts

De Strooper B, Vierbergen J, Balusu S, Horré K, Baligács N, T'svyen D, Chrysidou I, Sierksma A, Serneels L, Thal D, Verstreken P.   +10 more
europepmc   +1 more source

Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease. [PDF]

Cochrane Database Syst Rev
Nonino F, Minozzi S, Sambati L, Del Giovane C, Baldin E, Bassi MC, De Santis C, Gonzalez-Lorenzo M, Vignatelli L, Filippini G, Richard E.   +10 more
europepmc   +1 more source

A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer's disease. [PDF]

J Prev Alzheimers Dis
Chen T, Hutchison RM, Rubel C, Murphy J, Xie J, O'Gorman J, Dent G, Molenberghs G, Sormani MP, Hendrix S, Hansson O, Aisen P, Haeberlein SB, Tian Y.   +13 more
europepmc   +1 more source

Prospect in Alzheimer's disease integrative therapy targeting both amyloid-beta and tau. [PDF]

Neural Regen Res
Zhang W, Zhou Y, Chen J, Perez M, Claure X, Leblanc RM.   +5 more
europepmc   +1 more source

Stress-induced alteration of small extracellular vesicles drives amyloid-beta sequestration and exacerbates Alzheimer's disease pathogenesis. [PDF]

Alzheimers Res Ther
Zehra S, Rai S, Rani K, Choudhury SD, Rai H, Bhowmik S, Mohan N, Gupta A, Chatterjee P, Reddy TJ, Rani N, Modi GP, Nikolajeff F, Kumar S.   +13 more
europepmc   +1 more source

Type I interferon drives T cell responses to amyloid beta in the central nervous system. [PDF]

Nat Commun
Michel JJ, Sanghvi K, Rosenbauer J, Humbs L, Dierssen CT, Grudzenski-Theis S, Sachs V, Jähne K, Degenhardt K, Frölich L, Herms J, Fatar M, Platten M, Bunse L.   +13 more
europepmc   +1 more source